Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome. [electronic resource]
- Expert opinion on investigational drugs Sep 2003
- 1489-500 p. digital
Publication Type: Journal Article; Review
1354-3784
10.1517/13543784.12.9.1489 doi
Diabetes Mellitus, Type 2--drug therapy Humans Ligands Metabolic Syndrome--drug therapy Receptors, Cytoplasmic and Nuclear--agonists Transcription Factors--agonists